Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemoradiotherapy for locally advanced cardia adenocarcinoma
IRCT20140203016473N12Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of fluorouracil and cisplatin in gastroesophageal junction adenocarcinoma, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Tumor staging before and after chemoradiotherapy. Started Apr 2020; status: completed.
02
Drugs
fluorouracilcisplatin
03
Conditions
gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on IRCT20140203016473N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140203016473N12.